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Abstract
The liver plays a key role in removing harmful chemicals from the body and is therefore often the first tissue to suffer
potentially adverse consequences. To protect public health it is necessary to quantitatively estimate the risk of long-term
low dose exposure to environmental pollutants. Animal testing is the primary tool for extrapolating human risk but it is
fraught with uncertainty, necessitating novel alternative approaches. Our goal is to integrate in vitro liver experiments with
agent-based cellular models to simulate a spatially extended hepatic lobule. Here we describe a graphical model of the
sinusoidal network that efficiently simulates portal to centrilobular mass transfer in the hepatic lobule. We analyzed the
effects of vascular topology and metabolism on the cell-level distribution following oral exposure to chemicals. The spatial
distribution of metabolically inactive chemicals was similar across different vascular networks and a baseline well-mixed
compartment. When chemicals were rapidly metabolized, concentration heterogeneity of the parent compound increased
across the vascular network. As a result, our spatially extended lobule generated greater variability in dose-dependent
cellular responses, in this case apoptosis, than were observed in the classical well-mixed liver or in a parallel tubes model.
The mass-balanced graphical approach to modeling the hepatic lobule is computationally efficient for simulating long-term
exposure, modular for incorporating complex cellular interactions, and flexible for dealing with evolving tissues.
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Introduction
As the number of man-made environmental chemicals contin-
ues to grow, there is an urgent need to develop effective tools to
test their potential risk to humans. The number of environmental
chemicals that are produced in substantial quantities now numbers
approximately 10,000 [1]. In order to determine the potential risk
to humans of exposure to these compounds, it is critical to
establish a dose-response curve – the functional dependence of toxic
endpoints, e.g. hepatic lesions, on exposure to that compound.
Traditional long-term animal testing to determine dose-response is
time consuming, expensive, and requires the sacrifice of thousands
of animals without clear relevance to humans. Recognizing this
need for new approaches to toxicity testing [2,3,4], the U.S.
Environmental Protection Agency is conducting ongoing efforts to
collect in vitro data [5] to make inferences about in vivo toxicity in
both test animals [6] and humans [7].
Without appropriate context, in vitro testing is insufficient for
predicting effects in vivo. Context can be established through
informatics, i.e. correlating in vitro data with known in vivo
phenotypes, or modeling efforts in which abstract rules are
hypothesized to determine in vivo outcomes as a function of
variables, some of which may be determined in vitro. Whereas
empirical models describe the available data and are therefore
best limited to interpolation, physiologic models attempt to
describe the underlying biology in sufficient detail to emulate the
true dynamics. Physiologic models generate new hypotheses
which can subsequently be tested to refine the model. Both
informatics and modeling approaches create frameworks without
which there could be little meaningful interpretation of in vitro
data.
Our goal is to establish an in silico model for dose-response that
can be calibrated using in vitro characterizations of chemical effects.
The liver is often the site of initial exposure to hazardous
compounds and their metabolites due to first-pass metabolism of
blood from the gastro-intestinal tract via the hepatic vein. In
mammals the hierarchical structure of the liver terminates in 10
5
to 10
6 functional units called lobules [8] first identified by Kiernan
[9]. Each hepatic lobule receives blood from up to six portal triads,
each typically consisting of a hepatic arteriole and a portal venule
in addition to a bile ductule [10]. Blood flows through intervening
spaces between the cells, i.e. sinusoids [11], and drains into the
central vein. Hepatocytes are arranged in plates one to two cells
thick, organized radially around the central vein. A two-
dimensional slice of a hepatic lobule is shown in Figure 1.
Compounds within the blood are exchanged with the hepatocytes
sequentially as blood passes through the sinusoids. The action of
the enzymes within the hepatocytes on compounds produces
metabolites that may be more or less harmful than the parent
compound. Although mechanisms of chronic chemical-induced
injury are not completely understood, it is believed to involve
multiscale molecular and cellular interactions that culminate in
tissue damage.
Tissue dosimetry is traditionally estimated using physiologically-
based pharmacokinetic (PBPK) models. A PBPK model consists of
a system of ordinary differential equations (ODEs) for the
concentration of a compound (or compounds) in different tissues.
Typically some key tissues are treated as separate compartments
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tissues are modeled using aggregate compartments. More
complicated dynamics within a tissue, such as diffusion or
membrane transport, are often modeled with additional sub-
compartments but each sub-compartment is well-mixed. The
equations are parameterized by subject- or species-specific
physiologic parameters such as cardiac output and tissue volumes
as well as compound-specific parameters such as diffusion/
transport rates and tissue-specific plasma to tissue ‘‘partition
coefficients’’ corresponding to the assumption of a rapidly-
established equilibrium between concentration of compound
stored in the tissue and the concentration of compound in the
plasma flowing through the tissue. PBPK models relate the
concentration of compounds inhaled or ingested from the
environment to internal tissue doses [12,13,14].
In addition to the well-mixed approach, the parallel tubes model
of liver function has often been used to calculate in vivo hepatic
metabolism based upon in vitro measures such as intrinsic hepatic
clearance [15,16]. Typically used at steady-state, the parallel tubes
model assumes that each lobule is a tube connecting a portal triad
and central vein, along which concentration varies spatially.
Though in vitro studies typically average over the response of a
many hepatocytes within a well, hepatocyte function is known to
vary significantly in vivo [17], e.g., hepatocytes near the central vein
may express very different levels of enzymes than those nearer to
the portal triad. For this reason the lobule is divided into zones of
approximately similar hepatocyte function depending on location
within the lobule. The heterogeneity between these zones is
thought to arise from gradients in oxygen availability, exposure to
nutrients from the portal venules, and hormone concentration
[18]. Modeling the differences between regions of the lobule
should provide key insights into the differences between phenom-
ena observed in homogenous in vitro conditions and heterogeneous
in vivo reality.
The first multi-compartment geometric model of the liver was
developed by Andersen et al. [19]. In that model there were no
cells, but the concentrations of compounds in different zones of
lobules were modeled continuously and could therefore be coupled
to a PBPK model. Liu et al. [20] have followed a similar sub-
compartment coupled to PBPK approach for modeling zonal
heterogeneity due to transporters and enzymes. Recent approach-
es to simulating the response of the liver include that of Ohno et al.
[21] who coupled independent realizations of a model for cellular
dynamics into a linear array to allow some instances of the model
to be close to the source of nutrients and foreign compounds while
others were further removed. Ho ¨hme et al. [22] have developed a
discrete model of the hepatic lobule that considers the biochemical
forces between hepatocytes to simulate recovery following acute
chemical toxicity.
Ierapetritou et al. [18] recently conducted a thorough review of
liver tissue simulation approaches in which they summarize the
previously mentioned approaches as well as higher dimensional
models including fluid dynamics approaches based upon approx-
imations of the Navier-Stokes partial differential equations. Such
approaches are data- and computationally-intensive, especially
given the convoluted and dynamic cellular boundary of the
sinusoidal spaces.
Hunt et al. [23] have taken a unique agent-based approach with
individual hepatocytes represented by agents wherein metabolism
can occur. The environment of the agents is determined using a
hybrid graph and grid approach in which compounds are
represented by objects moving through the lobule. Cell-oriented
agent-based modeling (ABM) of tissues offers a number of unique
advantages [24,25]. First, since cells are the functional units of
tissues, the ABM has more physiologic relevance than a
continuum model. Second, the agent responses can be calibrated
and verified through comparison with actual cells in vitro (or ex vivo).
Third, spatial outcomes from the ABM can be translated to
histopathologic effects such as acute lesions and tumor formation.
While the agent-based strategy is suitable for modeling tissue
responses, the approaches to the liver taken so far have not
provided a framework for estimating tissue dosimetry. Though the
spatial distribution of a compound has previously been modeled,
past approaches have represented compounds as agents that are
Central Vein Central Vein
Sinusoids Sinusoids
Arteriole Arteriole
Portal Venule Portal Venule
Figure 1. Hepatic lobules receive nutrient-rich blood from the
gut through the portal venule and oxygen-rich blood from the
lungs through arterioles. Blood flows past sheets of hepatocytes
through the sinusoids and into the central vein. Image adapted from an
original by Amber Goetz, first published in [42].
doi:10.1371/journal.pcbi.1000756.g001
Author Summary
Virtual tissues are emerging as a powerful tool for
computational biology. By encoding known biology into
a simulation of tissue function, gaps in knowledge can be
identified. As a simulation of tissue function, in silico
experiments can be performed inexpensively and rapidly.
There are over 6000 chemicals produced in large quantities
that may be present in our environment, many of which
have not been thoroughly examined for human toxicity.
Traditional toxicity testing is expensive, lengthy, and relies
heavily upon the use of animals. For this reason in vitro
toxicity testing techniques are being developed. However,
techniques are needed to relate in vitro results to in vivo
conditions. The liver is often the first tissue to show signs
of toxicity and therefore a predictive liver toxicity simulator
would be a powerful tool to reduce the financial and
animal cost of toxicity testing. As a first step, we have
developed a model for relating environmental exposure to
cell-level concentrations; a model for virtual tissue
microdosimetry. We identify regimes in which this
approach is equivalent to previous techniques, as well as
regimes where large cell-to-cell variability exists. This
variability should have consequences both for normal
liver function and the onset of injury.
Microdosimetry in a Virtual Hepatic Lobule
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heterogeneity of the hepatic lobule, both molecular and cellular, it
is important to model the microanatomic distribution of chemicals
and to relate this to continuous variation in chemical concentra-
tion resulting from changes in human environmental exposure.
We have implemented a microdosimetry model that relates
whole-body chemical exposures to cell-scale concentrations. Our
objective was to develop the framework for simulating the
microanatomic distribution of various environmental chemicals
in a canonical lobule for extended periods of time ranging from
hours to months. This required an approach that is quantitative,
efficient in computational resources, and sufficiently flexible to
account for anatomic changes (due to chemical insult or other
factors) [26]. First, we approximated the microanatomic architec-
ture of the hepatic vasculature and parenchyma assuming a
discrete topology by a graphical model. This allowed us to
systematically explore the consequences of morphologic changes
on the concentration distribution. Second, we transformed the
sinusoidal elements of the vascular network into a system of
microscopic well-mixed compartments through which material
flow was assumed to be one-dimensional. Third, we connected the
virtual lobule to a PBPK model to relate individual exposure to
microdosimetry. For a range of physiologically relevant morpho-
logic parameters we evaluated the microdosimetry in response to
xenobiotic exposure levels and varying physico-chemical
attributes.
Results
Discrete Graphical Model of Sinusoidal Network
The two dimensional morphologic characteristics of the
mammalian hepatic lobule were represented as a discrete
connectivity graph, in which the edges captured spatial proximity.
The two main anatomic entities considered are hepatocytes, the
parenchymal cells responsible for the metabolism of chemicals,
and vasculature, i.e. sinusoids through which chemicals flow to the
hepatocytes. These are represented by different node types
including: hepatocytes, sinusoidal primitives, arterial and venous
sources, and the central vein, while edges represent connectivity
and spatial proximity between the nodes. Mass transfer through
the sinusoidal network occurs through edges: The edges
connecting vascular nodes transfer material through the sinusoids,
whereas edges between the vascular and cellular nodes exchange
material between the sinusoids and parenchyma.
A simplified geometry of the lobule was defined using the
following morphologic parameters: the number portal triads
(defining the vascular inputs), the branching factor of the sinusoids,
the number of sinusoids entering the central vein, and the sizes of
sinusoids, hepatocytes, and the lobule. The graphical model of the
lobule was constructed algorithmically using these parameters and
visualized spatially (Figure 2). The ‘‘virtual lobules’’ generated in
this manner presented a complex sinusoidal architecture repre-
senting a substantial challenge for estimating the distribution of
xenobiotics and nutrients.
Figure 2. The virtual lobule morphology is constructed
iteratively. First, sinusoids outward from the central vein (i). In
addition to small random variations in the direction of propagation, the
sinusoids branch into two sinusoids pointed away from the central vein
with probability Pbr (ii). Multiple sinusoids are started from the central
vein in an attempt to fill space (iii). Portal ‘‘triads’’ consisting of arterioles
and venules through which blood enters the lobule are added to the
perimeter of the lobule and connected to the vasculature (iv). Finally,
the sinusoids are lined with hepatocytes as space allows (v).
doi:10.1371/journal.pcbi.1000756.g002
Microdosimetry in a Virtual Hepatic Lobule
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(the algorithm is described in the methods section). The
sinusoidal network was constructed starting with the central vein
and extending radially outwards to the portal region. Beginning
with a node representing the central vein, sinusoid primitives
(nodes) were sequentially appended to form the initial vascula-
ture. Small random variations in the placement and branching of
sinusoidal primitives were used to reconstruct the histologic
appearance of a hepatic lobule. Second, the hepatic arterioles and
portal venules, were placed at the perimeter of the lobule and
connected sinusoidal network. Third, the parenchymal cells were
placed contiguously with the sinusoidal network. Because we
chose to connect the portal venule and arterioles to the central
vein in two dimensions the spatial layout was not completely
space-filling.
The approach described above is flexible, allowing the
generation of diverse lobular topologies through which flows can
be simulated. Five basic morphologies were examined, as depicted
in Figure 3, in which the number of portal triads (more accurately
dyads since bile was neglected), the probability of sinusoid
branching Pbr, and the presence of random noise were all varied.
No random noise or branching and one portal dyad produced a
lobule with a single tube (panel a in Figure 3) that in the limit of
many sinusoidal segments approaches a parallel tubes model. With
multiple portal dyads a classical lobule structure [27] that allows
both direct flow from the portal triads to the central vein and
mixing flow between portal triads is produced (panel b in Figure 3).
A 10% chance of sinusoid branching (panels c and d) produced
nearly space-filling lobule graph while a 5% chance of sinusoid
branching (panel e) did not.
Miller et al. (1979) observed that the branching of sinusoids is
greater near the portal triad than near the central vein [28].
Human lobules have been observed to typically have between
three and six portal triads per lobule [8,10,27], though many
‘‘triads’’ actually consist of dyads missing either an arteriole, bile
duct, or most commonly a portal venule [10]. Given these
observations, we believe that the geometries that include multiple
portal triads and random branching of the sinusoids (panels c, d,
and e) appear qualitatively more physiologic.
Blood Flow in the Sinusoidal Network
Blood circulation through the graphical model of the
vasculature was simulated as a network flow (Figure 4). Because
the sinusoidal diameter is much smaller than hepatocytes [29],
there are a large number of sinusoid primitives in each virtual
lobule. To efficiently solve for the flow, the sinusoid primitives
were aggregated into the following components: ‘‘straight’’ or
linear sequences and ‘‘branch’’ sections where straights meet
and mix. As shown in Figure 5, graph aggregation results in a
smaller graph that preserves the spatial distribution of the
sinusoids. Each aggregated node was assumed to be well-mixed,
that is, each constituent sinusoid primitive i has the same
concentration C
m
i (see Table 1 for a list of all symbols used in
this document).
Mass-balanced flow through the aggregate graph was deter-
mined by solving for the flow across each edge of the sinusoid
graph G(V,E) due to the sources at both the arterial and venous
elements of each portal triad. In general, solving for network flow
from node i to node j across edge Eij requires |E| different weights
Q
m
ij (i.e., flow rates). Mass-balance provides only |V| constraints –
one at each node – so additional constraints were needed.
We made use of the hemodynamical equivalent of Ohm’s law
[30,31]:
Q
m
ij~
Pj{Pi
Rij
where Pi is the pressure at node i and the resistance Rij:R was
assumed to have the same value R for all edges. We note that Rij
could be determined using schemes such as the cross-sectional area
of each branch. Hemodynamics provides |E| additional con-
straints, but introduces |V| additional unknown pressures Pi.
Together with mass balance we have |E|+|V| constraints for
|E|+|V| unknowns. This system of equations can be represented
with a matrix and, given source flows and outlet pressure, can be
solved by diagonalization. Since we are not currently interested in
sinusoidal pressure, R and the outlet pressure were taken as one.
This assumption does not effect the quantitative values of Q
m
ij since
they depend only on the relatively values of Pi.
As can be seen in Figure 4, randomly generating sinusoids can
lead to dead-end sinusoids for which no flow is predicted. These
sinusoids are removed from the lobule and additional hepatocytes
are added where possible.
To evaluate the appropriateness of these assumptions and the
suitability of the approach to arbitrary graphical structures, we
return to Figure 3, where predictions are made for a rat liver
lobule and compared to measurements made by Komatsu et al.
(1990) for the radial dependence of flow of erythrocytes in the
sinusoids with distance from the central vein. In vivo microscopy
was used by Komatsu et al. to observe the exposed livers of ten
Sprague-Dawley rats and flow was measured in three zones – near
the central vein, near the portal venule, and intermediate [31].
Flow was observed to increase with distance from the portal
venule, presumably as blood from the portal arteriole and other
portal triads mixed in. As can be seen on the left-hand side of
Figure 3, only geometries where random branching is present
(panels c, d, and e), produce profiles with increasing flow as the
central vein is approached. Given the indeterminacy in where flow
was measured relatively to the central vein, it is hard to
determining the precise radial profile of the flow. All geometries
produce mean flow within a factor of two of the measured values,
supporting the approximate appropriateness of this graphical
approach to hemodynamics in the hepatic sinusoids. A list of
simulation parameters used is given in Table 2.
Chemical Distribution in the Sinusoidal Network and
Cells
The final step needed to determine the concentration C
m
i for
each sinusoid i is to find the concentration of compound(s) in the
blood flowing into the liver. Our approach requires the rate and
chemical concentration(s) for blood flow from the gut and the
hepatic arteries. We used a simple PBPK model (Figure 6) with
oral and inhalation routes of exposure (PBPK model parameters
are listed in Table 3). Microdosimetry for each lobule was
determined from the pharmacokinetic exposure model by
assuming an arteriole flow equal to Q
m
art=Q liv/Rliv:lob/NPT and
a venule flow Q
m
ven=Q gut/Rliv:lob/NPT where Rliv:lob is the ratio
of liver to lobule volume and NPT is the number of portal triads
per central vein. Concentrations within the lobule are determined
by solving
d~ C C
m
dt
~Q
<:~ C C
m{~ M M:I
<:~ C C
m
where Mi is the summed clearance of all hepatocytes adjacent to
aggregate sinusoid i, and I is the identity matrix. Note that at
steady state the flow can be determined from just the geometry
Microdosimetry in a Virtual Hepatic Lobule
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Figure 3. Five different lobule morphologies were examined. They are: a) one portal triad, no branching or noise, b) six portal triads with
noise and additional sinusoids, c) six portal triads, 10% chance of branching, d) three portal triads with 10% branching, and e) six portal triads with 5%
chance of branching. Though the overall layout (middle column) can be compared qualitatively with physiology, we evaluate these geometries by
comparing the flow (left-hand column) predicted for a rat with in vivo measurements of flow in rat sinusoids (Komatsu et al. (1990) [31]). We also
compare (right-hand column) the radial dependence of concentration at tmax with the prediction for a well-mixed compartment with equivalent
metabolic clearance (heavy dashed line). Comparison of profiles b-e with profile a provides an approximate comparison to a parallel tubes prediction.
The solid line indicates the mean for multiple lobules and sinusoids, while the shading indicates the 95% quantile (variability).
doi:10.1371/journal.pcbi.1000756.g003
Microdosimetry in a Virtual Hepatic Lobule
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<:~ C C
m~~ M M:I
<:~ C C
m and
there is no need to solve for dynamic concentration changes, since
new concentrations can be calculated analytically.
For a completely physiologic, three-dimensional lobule Rliv:lob
would be equal to the number of lobules in the liver –
approximately 10
6 [32]. We determined Rliv:lob, the ratio of the
total volume of the liver to the total volume of the sinusoidal spaces
and hepatocytes in the simulated lobule, to be approximately 10
8,
which is roughly 100 times greater than the physiologic value. We
expect a greater value for two reasons: First, many components of
the lobule other than the sinusoidal spaces and hepatocytes, such
as endothelial and stellate cells, extracellular space, and bile ducts,
contribute to the volume of the lobule. Including these additional
components, and therefore increasing the volume of the simulated
lobule, will reduce Rliv:lob. Second, each simulated lobule is
assumed to have a thickness equal to a sinusoidal diameter
(23.5 mm [29]). As is illustrated in Figure 7, many (quasi-)two-
dimensional lobules are needed to fill the same volume (and thus
preserve mass balance) as single three-dimensional lobule. The
difference between Rliv:lob and the actual number of lobules
indicates that 100 simulated lobules are currently needed to fill the
space of a single physiologic lobule.
Using the lobule geometries (given in Figure 3) ensembles of ten
lobules were used for simulating blood flow. For each geometry the
flow was simulated for an oral exposure of 10 mMol total
(equivalent to 0.03 mg per kg body weight for a 200 molecular
weight compound and a 70 kg subject) with an intrinsic hepatic
clearance due to metabolism of 10 mL/min/million hepatocytes.
We compared the average concentration throughout the lobule
SCmT, as predicted by our approach, with the prediction Cliv for a
PBPK model with a well-mixed liver compartment with equivalent
metabolic clearance CL~Rliv:lob
P
i
Mi (i.e. the product of the
clearance per hepatocyte, the total number of hepatocytes in a
lobule, and the effective number of lobules Rliv:lob). It is important
to note that the overall pharmacokinetics depends on the lobule
layout because the effective number of lobules Rliv:lob is
determined by volume alone and therefore the total clearance of
the liver depends on the number of hepatocytes relative to the
volume of the lobule.
Though the overall clearance varied with geometry, the impact
of different geometries on the average concentration in the lobule
was small. As shown in Figure 8, for the assumed metabolism rate
the mean predicted concentration did not vary greatly from what
would be predicted for a more traditional well-mixed compart-
ment. To compare results between geometries the concentrations
were scaled by Cliv predicted for the appropriate CL. We find that
in all cases the predicted average concentration slightly exceeds the
well-mixed PBPK prediction, but that otherwise the pharmaco-
kinetics are very similar.
Plotted on the right-hand side of Figure 3 is the radial-
dependence of concentration on position relative to the central
vein at tmax – the time at which the lobule reaches maximum
average concentration, SCmTmax. In all cases the mean concen-
tration decreased slightly from the portal triads to the central vein
– the predicted concentration was similar to the parallel tubes
model. Thus, the mean predictions were similar to typical
approaches for predicting liver concentrations.
Geometry had a much greater impact on the variability in
predicted concentrations Figure 3. For all the lobules with random
branching great variability was observed at the edges of the lobule,
maximally distant from the central vein. Some regions receive
slightly higher concentrations while other, stagnant regions
received almost none. This supports the idea of considering
sinusoidal topology for estimating changes in the local environ-
ment of a hepatocyte in addition to radial location between the
central vein and the portal triad (i.e. zone I, II, or III). Since there
were not large differences between the predictions for the three
lobules with random branching, we arbitrarily chose to simulate
lobules with six portal triads and 10% chance of branching
CV CV
PT PT
PT PT
b) b)
CV CV
PT PT
PT PT
c) c)
CV CV
PT PT
PT PT a) a)
Figure 4. Sinusoid connectivity was represented with a graph.
Spatial proximity between sinusoids within simulated lobule (a) was
used to generate connectivity graphs (b), which are aggregated (c) in
order to solve for flow from the portal triads to the central vein using
ODEs.
doi:10.1371/journal.pcbi.1000756.g004
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paper. A larger ensemble of fifty lobules was generated for these
studies.
Chemical Kinetics
To test whether a continuum approximation (ODEs) was
appropriate for modeling mass transfer in the sinusoidal graph we
estimated the number of molecules at a hepatocyte. If the number
of molecules at higher concentrations is not large enough a
stochastic approach [33] would be preferable. As shown in
Figure 9, the upper bound on the number molecules at a total dose
of 10 mM is was nearly a million molecules per hepatocyte, as
calculated by multiplying the concentration in the sinusoid
8
1
2
4
3
5
6
8
7
Central vein
1
3
4
5
6
7
Sinusoidal 
Primitive
2
Straight Aggregate Node
Branch Aggregate Node
Figure 5. Similar nodes were aggregated to reduce the complexity of the sinusoid connectivity graph.
doi:10.1371/journal.pcbi.1000756.g005
Table 1. List of Symbols.
Symbol Definition
Pbr Sinusoidal Branching Probability
G(V,E) sinusoid graph consisting of vertices (nodes) V and edges E
Q
m
ij Micro flow rate (L/h) across from node i to node j
Fi Total flow into node i
Q
m
art Micro flow rate (L/h) through each arteriole
Q
m
art Micro flow rate (L/h) through each venule
Rliv:lob Ratio of liver to lobule volume
Qgut Flow rate (L/h) through gut tissue
Qliv Flow rate (L/h) of arterial blood into liver
C
m
i Concentration of within aggregate sinusoid i and each constituent
sinusoid
Cliv Concentration for a well-mixed liver compartment
SCmT Concentration averaged over the lobule
SCmTmax Maximum concentration averaged over the lobule
C
m
i,max Maximum concentration within aggregate sinusoid i
tmax Time at which maximum average concentration is reached
doi:10.1371/journal.pcbi.1000756.t001
Table 2. Lobule Simulation Parameters.
Oral dose 10 mMol
Number of Lobules per Ensemble Analyzed 50
Agent-based model steps per Iteration 8
time per iteration 0.2 h
Total hours simulated 5
Number of Portal Triads 6
Number of Sinusoid starts at central vein 6
Sinusoidal Branching Probability Pbr 10%
Radius of Lobule 15 hepatocytes
diameter of hepatocyte 100 mm (assumed)
Thickness of lobule 23.5 mm [29]
Diameter of sinusoid primitive 25 mm [29]
doi:10.1371/journal.pcbi.1000756.t002
Microdosimetry in a Virtual Hepatic Lobule
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hepatocytes accessing that sinusoid. Though a small fraction of
hepatocytes are exposed to almost no molecules, a continuum
approach appears appropriate.
The maximum concentration in the tissue following a dose is a
commonly used measure of tissue exposure in pharmacokinetics.
For the simulated lobule a local C
m
i,max can be calculated for each
hepatocyte as a result of different sinusoids receiving different
concentrations. Figure 10 shows the distribution of C
m
i,max
experienced by all the hepatocytes in an ensemble of fifty lobules
with intrinsic hepatic metabolic clearance of 10 mL/min/million
hepatocytes. The values have been normalized to the Cmax
predicted for a well-mixed liver with the same overall metabolic
clearance (indicated but the solid line). The peak for the
distribution is in excess of the well-mixed prediction, while the
breadth is quite wide, indicating that at this rate of metabolism
some hepatocytes receive exposures nearly 40% greater than
would be predicted for a well-mixed liver while others receive
almost no exposure.
Ito and Houston [15] summarize a range of intrinsic
metabolism rates including values as low as 1.4 mL/min/million
hepatocytes (caffeine) and as large as 1800 mL/min/million
hepatocytes (propranolol). This wide variability in metabolism
rate has consequences for the variability predicted across the
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Figure 6. A physiologically-based pharmacokinetic model was used to relate oral and inhalation exposure to blood flow into the
liver.
doi:10.1371/journal.pcbi.1000756.g006
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by different hepatocytes grows from a few percent to nearly 800%
for a metabolism rate of 1000 mL/min/million hepatocytes. For
rapid metabolism those hepatocytes first exposed to blood from
the portal triad receive eight times the exposure that would be
predicted for a well-mixed liver, while downstream hepatocytes
receive almost no exposure to the parent compound.
Heterogeneity within the lobule is dynamic [34]; a low
metabolism rate may be due to limited distribution of metabolizing
enzymes, while a high rate of metabolism may lead to induction of
enzymes, perhaps heterogeneously. Both of the distributions in
Figure 9 and Figure 10 are broad, indicating that the average
response of the ensemble is not necessarily characteristic of the
response of any one simulated lobule. Given that these and other
variability have been observed, any model of hepatic effect that
depends upon local concentrations, particularly threshold models,
may have a different response for a spatially-extended simulation
than with a well-mixed simulation. The relevance of this
heterogeneity will depend on the parameter regime – for low
metabolism and little variability, the well-mixed approximation is
likely to be sufficient. If large variability is present, e.g. for rapidly
metabolized compounds, it may be crucial to determine which
hepatocytes receive large exposures. This is especially useful for
modeling spatial effects such as the development of lesions in one
region, but not another.
Impact of Microdosimetry on Hepatocellular Responses
We conducted a preliminary analysis of the cellular effects due
to microdosimetry using a simple agent-based model for
hepatocytes. Each agent was defined by a fixed, identical
xenobiotic metabolism rate, and functional states that were
updated at each time step via state transition rules. A simple
approach was used to encode probabilistic state transition rules
conditioned on inputs from the agent environment. Future cellular
models will be able to take better advantage of the freedom to
proliferate and move provided by this approach since flow for a
new arrangement can be determined rapidly by updating the
sinusoid and contact graphs. Here we considered normal
hepatocytes and cell death following exposure to threshold
cytotoxic concentration. The ABM was integrated with the
sinusoidal flow model with each being updated alternately. We
simulated twelve minutes of the flow followed by eight iterations of
the ABM – intended to be sufficiently small time periods for each
model to respond realistically to changes in the other. Experi-
mental verification will be needed to determine the appropriate
time scales.
Given the current cellular model and the predicted increase in
variability with metabolism rate shown in Figure 11, two types of
comparisons were made: a spatially-extended hepatic lobule with
an approximate ‘‘parallel tube’’ model (given by the lobule
geometry in Figure 3a) and variability due to rapid metabolism for
low (1 mL/min/million hepatocytes) and high (1000 mL/min/
million hepatocytes) rates of metabolism. An arbitrary threshold of
chemical concentration has been assumed, above which cell stress
and apoptosis become much more common. Since different
metabolic clearances and lobule geometries lead to different
pharmacokinetics the simulations were normalized by varying the
threshold for enhanced apoptosis – the threshold was set to 110%
of the maximum average lobule concentration predicted for each
configuration.
For a well-mixed lobule, a threshold in excess of maximum
lobule concentration should have no effect. Instead, as shown in
Figure 12 we observed that spatial heterogeneity in toxicant
concentration across the lobule enhanced cell injury before the
chemical was cleared. This effect was not observed in the
approximate parallel tubes model. Enhanced cell death was not
observed at low xenobiotic metabolism rates in the spatially-
extended lobule. Though there is some baseline apoptosis at the
lower metabolism rate, there is roughly five times greater
apoptosis for higher metabolism, i.e. greater variability in
exposure. This suggests that lobular geometry is not solely
responsible for the cell behavior and hepatocyte metabolism is
required for the variability in the cellular response. Variation in
cellular responses is frequently observed [17] and is thus
physiologically relevant. While additional work is required to
evaluate the responses in our model, these findings suggest the
value of spatially extended tissue level models of microcirculation
and cellular dynamics.
Discussion
We have described a microdosimetry model to relate environ-
mental exposures to cellular exposures. This is only a step toward
developing virtual tissues that can predict the in vivo consequences
of chemical exposure based upon in vitro information.
The liver lobule is known to be spatially heterogeneous [18,34].
Zonal differences between central and peripheral hepatocytes
include oxygen availability, hormone concentration, expression of
metabolizing enzymes, (e.g., CYP 3A4), gluconeogenesis, and
glycolysis [18]. One clear conclusion of this modeling work is that
morphology of the liver alone is insufficient to explain the
observed zonation in hepatocyte function or even gradients in
concentration across the lobule. We observed variations that are
driven by the action of hepatocytes, i.e. metabolism, and not by
geometry alone.
A model for a spatially-extended hepatic lobule sets the stage for
investigating emergent behavior in models of hepatocyte function.
If the action of hepatocytes creates spatial variation across the
lobule then any cellular dynamic response that depends on
chemical or nutrient concentration may in turn be altered, which
could be a prelude to zonal patterns of biological functions. More
extreme effects, such as central lobular necrosis, may be due to the
transformation of the compound via metabolism into a more
Table 3. Parameters Used for PBPK Model.
Parameter Value Source
Qcard 336 L/h [43]
Qgut 66 L/h [43]
Qliv 18 L/h [43]
Qgfr 7.5 L/h [43]
Qrest 252 L/h [43]
Bodyweight 70 kg assumed
Lean Fraction of BW 0.7 [19]
Vart, Vven 0.025 L/kg lean bw [19]
Vgut 0.0165 L/kg bw [19]
Vliv 0.035 L/kg lean bw [19]
Vlung 0.27 L [44]
Vrest 0.6 L/kg bw –
(Vart+Vven+Vgut+Vliv+Vlung)
[43]
kad,k inh,K rest:plas,K liv:plas,
Kgut:plas,R blood:plas,f
1 assumed
doi:10.1371/journal.pcbi.1000756.t003
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hepatocytes.
In contrast to the well-stirred model of the liver, the simulated
lobule provides a means of accessing a variety of inter- and
intracellular dynamics. Though the results we obtain are in some
respects similar to previous models, we gain the additional
capability of allowing hepatocyte-specific dosimetry as well as
the potential to alter lobule geometry, e.g. lesions or necrosis, in
response to chemical injury. Since numerical approaches often
allow even large systems of ODEs to be solved much more rapidly
than analogous systems of PDEs [35] and since numerous
algorithms exist for analysis of graphs [36], we believe this
approach is tractable for simulating sub-chronic and chronic
xenobiotic exposure scenarios while preserving mass-balance.
Central Vein Central Vein
Sinusoids Sinusoids
Arterioles Arterioles
Portal  Portal Venules Venules
Figure 7. A physiologic lobule is a three-dimensional polyhedron with a volume between 0.1 and 0.9 mL [8]. Our (quasi-)two-
dimensional simulated lobule is assumed to have a thickness equal to a sinusoidal diameter (23.5 mm [29]). Therefore many identical simulated
lobules in parallel are needed to fill the volume of one physiologic lobule. Blood flow to the simulated lobules is divided by Rliv:lob, the ratio of the
volume of the whole liver to the volume of single lobule.
doi:10.1371/journal.pcbi.1000756.g007
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micro-anatomic structures (other cell types, extracellular matrix,
bile ducts, etc.) can be included incrementally without significant
changes in our approach.
In contrast to computationally intensive, spatially continuous
approaches such as fluid dynamics, this graph-theoretic approach
has hopefully sacrificed little physiologic detail but gained a great
deal in terms of computational efficiency. Calculating hemodyna-
mical flow on a graph allows rapid determination of flow given
minimal boundary conditions, which will be especially useful for
recalculating flow as morphology changes (e.g. lesion formation) or
as individual sinusoids are temporarily blocked (e.g. Kupffer cells).
A faster dosimetry model allows the focus to center on cellular
phenotypes, which are the key to modeling disease pathogenesis. A
computationally-tractable approach allows for simulating the long
run times associated with sub- and chronic toxicity studies as well
as simulating large populations.
We evaluated our approach to hepatic blood flow in three ways.
First, we qualitatively tuned the appearance of the lobule to match
actual physiology. Second, we compared the predicted pharma-
cokinetics for our spatially-extended lobule with traditional
approaches, finding regimes in which our approach reduced to
the well-mixed liver and the parallel tubes model. Third, we
quantitatively compared the flow predicted for a rat with
observations made in vivo of actual flow. Though all three lines
of evaluations supported our approach, they also all pointed
toward further refinements that may be necessary for simulating
dose-response.
This work addresses the dose portion of the dose-response
curve, allowing assessment of how changes in exposure impact the
hepatic lobule. The greater body of work remains with modeling
response. Sufficiently complex models for hepatocellular dynam-
ics, and eventually models for additional cell types, especially the
Kupffer cells responsible for inflammatory responses, must be
Figure 8. Average concentration throughout lobule for the five morphologies depicted in Figure 3. The ensemble average for all five
lobules is very similar to the well-mixed lobule prediction (indicated by the dashed line) however the different morphologies produce different
whole-liver clearances because the number of hepatocytes as a fraction of the volume of the simulated lobule is geometry-dependent.
doi:10.1371/journal.pcbi.1000756.g008
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function. It remains to be seen whether three-dimensionality or
even a departure from the classical lobule paradigm to simulate
multiple lobules will be needed.
To establish the safety of a compound one ideally finds the
dose-response curve for various toxicity endpoints, so that an
acceptable level of exposure can be determined. Currently the
gold standard of toxicology is animal testing, but the need and
desire for inv i t r otesting is growing. An in silico model for
predicting dose-response would, at a minimum, provide a screen
for prioritizing compounds that requiring further testing and
perhaps may ultimately be able to predict in vivo consequences for
the large number of compounds for which there is little or no
toxicity data.
T h em u l t i s c a l ea p p r o a c hd e s c r i b eh e r ei si n t e n d e dt ob ef a s t
and verifiable, and would allow the determination of whether an
observed in vitro response is relevant in vivo. The limitations in
developing a homeostatic model of liver function are not
computational, but biological. Additional data is needed,
especially information on the statistical distribution of lobule
morphology and the determination of cell state in response to
local inputs. This model provides a framework for making use of
two types of readily available data – histopathology slides and in
vitro measures of cell function. In all likelihood direct
comparison to liver toxicology data will be met initially with
more failures than successes, but where we initially fail we will
learn.
Histopathology images have long been used to obtain
information on microanatomic regions, vasculature, individual
cells, cell types, and cell phenotypes from two- and three-
dimensional images. Though traditionally time-intensive, ad-
vances in automated extraction of information from histopa-
Figure 9. The distribution of the number of molecules at each hepatocyte following a total dose of 10 mMol.
doi:10.1371/journal.pcbi.1000756.g009
Microdosimetry in a Virtual Hepatic Lobule
PLoS Computational Biology | www.ploscompbiol.org 12 April 2010 | Volume 6 | Issue 4 | e1000756thology images are making it possible to analyze these images at
a single cell resolution [37,38,39]. Additionally it is possible to
extract information about the functional state of cells using
cytomorphologic features or molecular markers [40]. Though
cell-scale assay technology is still developing, it will be essential
for fully calibrating and evaluating models such as this in order
to provide simulated in vivo context for the results of in vitro
assays.
True variability in the response of a given hepatocyte is either a
product of independent microdosimetry and cell variability, or is a
function of the two, depending on the degree of correlation. To
determine the significance of a chemical perturbation it is not
enough to understand the cellular dynamics, but also the context
in which those dynamics exist – i.e., microdosimetry.
Methods
Microdosimetry Model of a Lobule
We have implemented a microdosimetry model for relating
whole-body chemical exposures to cell-scale concentrations. The
model is written in the freely available statistical language R,
version 2.8.1 [41].
Generating Sinusoidal Morphology
Given morphologic parameters Nt, the number of portal triads;
Ns, the number of sinusoids per source/sink; Pbranch, the
probability of a sinusoid branching; and Dmax, the size of the
lobule, and calculating hCV is the angle to the central vein, given
current position:
Figure 10. The distribution of maximum concentration experienced by hepatocytes relative to the prediction of a well-mixed PBPK
model (solid line).
doi:10.1371/journal.pcbi.1000756.g010
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2. For each of Ns sinusoids:
1. Select initial angle h
0
s
2. Place sinusoidal primitive on edge of central vein at h
0
s
3. Call the sinusoid placement algorithm (SPA) with hs=h
0
s
4. Increment h
0
s approximately 2p/Ns
3. For each of Nt portal triads:
1. Select initial angle ht
2. Place a periportal vein at angle ht and distance 0.8*Dmax
3. For each of Ns sinusoids:
1. Select initial angle h
0
s=hCV
2. Place a sinusoid primitive on edge of the periportal vein
at h
0
s
3. Call SPA with hs=h
0
s
4. Increment h
0
s approximately 2p/Ns
4. Place an arteriole randomly at the edge of the periportal
vein
5. For each of Ns sinusoids:
1. Select initial angle h
0
s=hCV
2. A sinusoid primitive is placed at the edge of the arteriole
at h
0
s and the SPA is called with hs=h
0
s
3. h
0
s is incremented approximately 2p/Ns
Recursive Sinusoid Placement Algorithm (SPA):
Figure 11. The breadth of the distribution of maximum exposure received by individual hepatocytes, i.e. variability in exposure,
grows with the clearance rate. The shaded region indicates the 95% interval.
doi:10.1371/journal.pcbi.1000756.g011
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using hs
2. If either the distance from the central vein exceeds Dmax or
the potential location overlaps with a previously placed
sinusoid, then
1. Return
3. If a randomly drawn number [0,1] is less than Pbranch, then
1. Randomly select h’s from the interval [hCV2p/2, hCV+p/2]
2. Call SPA with angle hs=h’s
4. hs is randomly perturbed
5. Call SPA
Reducing the Complexity of the Sinusoidal Graph
The aggregation process is performed using the following
algorithm:
1) All sinusoid primitive nodes are assigned a corresponding
aggregate node (CAN) initially set to NULL
2) For each sinusoid node I adjacent to the central vein, if the
CAN is NULL, then,
a. if the number of sinusoid neighbors N
i
n=1, a ‘‘dead
end’’ CAN is created,
b. if N
i
n=2, a ‘‘straight’’ CAN is created
c. if N
i
n.2 a ‘‘branch’’ CAN is created
d. For each neighbor j, If N
i
n=N
j
n then,
i. The CAN for j is set to the CAN for i unless the
CAN is a straight node already consisting of 5
sinusoid primitive nodes
ii. Step 2d is called recursively for node j
3) Repeat step 2 for each arterial and venous source
4) For each branch CAN i,
Figure 12. The predicted number of apoptotic cells, caused by locally exceeding a threshold of 110% of the maximum average liver
concentration, is negligible for a spatially-extended lobule when the metabolism rate is low (lower curve). For a rapidly metabolized
compound (upper curve) variability in exposure causes some apoptosis in the spatially-extended lobule. The shaded region indicates the 95%
interval.
doi:10.1371/journal.pcbi.1000756.g012
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PLoS Computational Biology | www.ploscompbiol.org 15 April 2010 | Volume 6 | Issue 4 | e1000756a. For each neighbor j if j is also a branch then CAN i is
absorbed into CAN j
5) For each straight CAN i, if there is now only one neighbor
and that neighbor is a branch CAN, merge i with the
neighbor
6) For each branch CAN i, if there is only one neighbor
convert I into a dead end CAN
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